Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,120) with videos related to
Page
of 112
Sort By:
Avian Pathology : Journal of the W.V.P.A
|
July 1, 1985
Antigenic and biological characterisation of avian paramyxovirus type I isolates from pigeons--an international collaborative study
D J Alexander, P H Russell, G Parsons, et al.
Haematologica
|
December 9, 2017
Melphalan 140 mg/m<sup>2</sup> or 200 mg/m<sup>2</sup> for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party
Holger W Auner, Simona Iacobelli, Giulia Sbianchi, et al.
British Journal of Haematology
|
July 14, 2020
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial
Graham H Jackson, Charlotte Pawlyn, David A Cairns, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2016
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
Victoria T Potter, Simona Iacobelli, Anja van Biezen, et al.
Blood
|
May 1, 2024
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML
Jad Othman, Nicola Potter, Adam Ivey, et al.
Plos Medicine
|
January 11, 2021
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial
Graham H Jackson, Charlotte Pawlyn, David A Cairns, et al.
Nature Communications
|
August 8, 2022
Unified classification and risk-stratification in Acute Myeloid Leukemia
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Haematologica
|
June 6, 2020
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial
Graham H Jackson, Faith E Davies, Charlotte Pawlyn, et al.
Blood
|
November 14, 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18
Steven Knapper, Laura W Dillon, Malavika Babu, et al.
Genome Research
|
September 15, 2022
The western redcedar genome reveals low genetic diversity in a self-compatible conifer
Tal J Shalev, Omnia Gamal El-Dien, Macaire M S Yuen, et al.
Page
of 112
Search research articles
Search
Showing results (1091-1100 of 1,120) with videos related to
Sort By:
Page
of 112
Avian Pathology : Journal of the W.V.P.A
|
July 1, 1985
Antigenic and biological characterisation of avian paramyxovirus type I isolates from pigeons--an international collaborative study
D J Alexander, P H Russell, G Parsons, et al.
Haematologica
|
December 9, 2017
Melphalan 140 mg/m<sup>2</sup> or 200 mg/m<sup>2</sup> for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party
Holger W Auner, Simona Iacobelli, Giulia Sbianchi, et al.
British Journal of Haematology
|
July 14, 2020
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial
Graham H Jackson, Charlotte Pawlyn, David A Cairns, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2016
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
Victoria T Potter, Simona Iacobelli, Anja van Biezen, et al.
Blood
|
May 1, 2024
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML
Jad Othman, Nicola Potter, Adam Ivey, et al.
Plos Medicine
|
January 11, 2021
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial
Graham H Jackson, Charlotte Pawlyn, David A Cairns, et al.
Nature Communications
|
August 8, 2022
Unified classification and risk-stratification in Acute Myeloid Leukemia
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Haematologica
|
June 6, 2020
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial
Graham H Jackson, Faith E Davies, Charlotte Pawlyn, et al.
Blood
|
November 14, 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18
Steven Knapper, Laura W Dillon, Malavika Babu, et al.
Genome Research
|
September 15, 2022
The western redcedar genome reveals low genetic diversity in a self-compatible conifer
Tal J Shalev, Omnia Gamal El-Dien, Macaire M S Yuen, et al.
Page
of 112